Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Phase NKTX Q1 2026 Earnings Narrowing Loss and Stable Stock Performance Interparfums Inc Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Home BancShares Inc HOMB Q1 2026 Earnings Slight EPS Miss Masked by Strong Underlying Trends